XML 76 R65.htm IDEA: XBRL DOCUMENT
v3.25.1

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions | 3 Months Ended
--- | ---
Mar. 31, 2025 | Mar. 31, 2024
Disaggregation of Revenue [Line Items] |  |
Net sales | $ 4,663 | $ 3,856
MedSurg |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 1,577 | 1,412
Cardiovascular |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 3,085 | 2,445
U.S. |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 2,960 | 2,258
U.S. | MedSurg |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 1,093 | 941
U.S. | Cardiovascular |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 1,868 | 1,316
International [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 1,702 | 1,599
International [Member] | MedSurg |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 484 | 470
International [Member] | Cardiovascular |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 1,218 | 1,129
Endoscopy [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 673 | 642
Endoscopy [Member] | U.S. |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 420 | 395
Endoscopy [Member] | International [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 253 | 247
Urology [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 633 | 513
Urology [Member] | U.S. |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 469 | 356
Urology [Member] | International [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 165 | 157
Neuromodulation [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 271 | 256
Neuromodulation [Member] | U.S. |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 204 | 190
Neuromodulation [Member] | International [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 67 | 66
Interventional Cardiology Therapies |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 697 | 652
Interventional Cardiology Therapies | U.S. |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 232 | 195
Interventional Cardiology Therapies | International [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 465 | 457
Watchman |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 425 | 344
Watchman | U.S. |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 390 | 311
Watchman | International [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 34 | 33
Cardiac Rhythm Management [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 578 | 575
Cardiac Rhythm Management [Member] | U.S. |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 358 | 354
Cardiac Rhythm Management [Member] | International [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 220 | 221
Electrophysiology [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 730 | 300
Electrophysiology [Member] | U.S. |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 511 | 158
Electrophysiology [Member] | International [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 219 | 143
Cardiology [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 2,429 | 1,872
Cardiology [Member] | U.S. |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 1,491 | 1,017
Cardiology [Member] | International [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 938 | 854
Peripheral Interventions [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 656 | 573
Peripheral Interventions [Member] | U.S. |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | 376 | 299
Peripheral Interventions [Member] | International [Member] |  |
Disaggregation of Revenue [Line Items] |  |
Net sales | $ 280 | $ 274

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 9: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_WatchmanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |